Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia. Fleischman RA. N Engl J Med 2025;393:2279.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fleischman RA. Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia. N Engl J Med 2025;393:2279.
PMID: 41337729